Clinical trials represent tomorrow’s medicine today, yet not every patient confronting a myeloma diagnosis is informed about all available care options. Surprisingly, some patients and their care partners are never introduced to the possibility of participating in clinical trials. How can we alter the course? What strategies can healthcare professionals (HCPs) employ to effectively communicate information about clinical trials and guide patients through next steps? Join this HCP-to-HCP discussion and glean important insights from esteemed experts Dr. Beth Faiman and RuthAnn Gordon.
- Understanding the critical role of clinical trial nurses
- HCP-to-HCP recommended strategies to effectively communicate about pre-trial eligibility determination and the consenting process
- How to educate and mentor nursing professionals in community hospital settings, guiding them to assist patients and families through the subsequent steps of participating in a clinical trial
Register to watch online on Tuesday, February 6 @ 10 AM Pacific | 1 PM Eastern. This roundtable is moderated by a fellow HCP.
The webinar will be recorded. If you would like to share it with others, the replay will be available within the next few days. To receive a link to the recording, please register and you will be notified when it’s available.I'll be at the February 6th HCP Roundtable: Best Practices for Talking About Clinical Trials With Myeloma Patients webinar. Join me! Click To Tweet
Advocacy Promotional Partners
This program is brought to you by the Patient Empowerment Network. It is made possible through support from Bristol Myers Squibb and generous donations from people like you.